Benzinga's Top Downgrades

Analysts at RBC Capital downgraded United Technologies Corporation UTX from Outperform to Sector Perform. United Technologies shares closed at $104.37 on Monday. Analysts at Leerink Swann downgraded Sarepta Therapeutics Inc SRPT from Market Perform to Underperform. The target price for Sarepta Therapeutics has been lowered from $13 to $5. Sarepta Therapeutics shares fell 0.45 percent to $17.84 in pre-market trading. Wunderlich downgraded Brocade Communications Systems, Inc. BRCD from Buy to Hold. The target price for Brocade Communications has been lowered from $10.50 to $9. Brocade Communications shares declined 0.82 percent to $8.44 in pre-market trading. HSBC downgraded Sanofi SA (ADR) SNY from Buy to Hold. Sanofi shares dropped 1.25 percent to $40.94 in pre-market trading. Analysts at Barclays downgraded Visteon Corp VC from Overweight to Equal-weight. The target price for Visteon has been raised from $83 to $85. Visteon shares gained 1.04 percent to close at $80.50 on Monday. Canaccord Genuity downgraded Barrick Gold Corporation (USA) ABX from Buy to Hold. Barrick Gold shares rose 0.63 percent to $19.23 in pre-market trading.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!